In 2023, the global healthcare regulatory affairs outsourcing market was estimated to be valued at US$ 2,203.40 million. During the forecast period, the market is likely to garner a moderate CAGR of 6.70%. By 2034, the market is predicted to gain a valuation of US$ 4,052.30 million by 2034.
| Report Attribute | Details |
|---|---|
| Estimated Market Value in 2023 | US$ 2,203.40 million |
| Expected Market Value in 2024 | US$ 2,118.60 million |
| Projected Forecast Value in 2034 | US$ 4,052.30 million |
| Anticipated Growth Rate from 2024 to 2034 | 6.70% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Market players are offering healthcare firms with functional outsourcing to enhance efficiency. These outsourcing companies offer the healthcare forms to contract multiple monitors (CRAs), coordinators, senior monitors, and project managers for a particular period of time. This would help them to support the internal resources without the expansion of their own clinical team.
The outsourcing services have dedicated clinical experts working under the project management of the clients. They mostly offer FTE based budgets, with predictable and fixed pricing.
Healthcare companies will have a single point of contact with these outsourcing firms. All the staffing requirements, from changing needs to operational and financial management of the projects, will be taken care of.
The global demand for the healthcare regulatory affairs outsourcing market was estimated to reach a valuation of US$ 1,123.80 million in 2018, according to a report from Future Market Insights. From 2018 to 2023, the healthcare regulatory affairs outsourcing market witnessed significant growth, registering a CAGR of 12.10%.
| Historical CAGR from 2018 to 2023 | 12.10% |
|---|---|
| Forecast CAGR from 2024 to 2034 | 6.70% |
The growth of biotechnology and pharmaceutical companies is a major factor driving the healthcare regulatory affairs outsourcing market as they require effective regulatory plans and submissions.
Companies are spending more and more on outsourcing partners for specific regulatory knowledge as they struggle to bring new goods to market. This helps them navigate complex regulatory frameworks, gain a competitive edge, and ensure compliance and timely market entrance
Principal Consultant
Cost Savings, Increased Efficiency and Regulatory Compliance to Push Companies toward these Services
Companies can avoid the overhead expenses associated with having an in-house regulatory affairs staff. With outsourcing, companies may pay for just the work completed, giving them flexibility.
Efficiency gains are possible through outsourcing. There are various kinds of core and non-core activities within a healthcare company. By outsourcing the non-core activities, companies can devote more time towards the core activities and enhance the efficiency.
With the evolving regulatory framework of various bodies, the healthcare companies find it quite difficult to abide by it all at the same time. They prefer to outsource such responsibilities to a third company that holds better knowledge of all these.
High Initials Costs and Technological Challenges to Restrict Market Growth
Healthcare regulatory affairs outsourcing services have a lot of advantages for the healthcare companies. But there are some serious complications with data too. By outsourcing services, healthcare companies will face a loss of control over their own critical processes.
Companies have to provide the outsourcing forms with their complete set of data, which can lead to patient data leak and vulnerabilities. A lack of direct monitoring and control over outsourced medical billing and collections could make patient data vulnerable. Factors such as these can hinder the global market growth eventually.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
This section focuses on providing detailed analysis of two particular market segments for the healthcare regulatory affairs outsourcing, the dominant service type and the significant end user. The two main segments discussed below are the regulatory writing and publishing service and mid-size pharmaceutical companies.
| Services | Regulatory Writing and Publishing |
|---|---|
| Market Share in 2023 | 33.60% |
In 2023, the regulatory writing and publishing service was estimated to gain a market share of 33.60%. This is because there is a growing need for thorough documentation and submission assistance.
Companies are looking for qualified experts to guarantee correct and timely submissions due to changing legislation and tighter compliance standards. Companies in the healthcare sector can improve productivity, simplify procedures, and successfully comply with regulations by outsourcing these jobs.
| End User | Mid-Sized Pharmaceutical Companies |
|---|---|
| Market Share in 2023 | 29.20% |
In 2023, the mid-size pharmaceutical companies were estimated to be the dominant end user for the healthcare regulatory affairs outsourcing market. They may accelerate product development schedules, handle complicated compliance needs with efficiency, and concentrate resources on key capabilities by outsourcing regulatory affairs.
The ability to obtain expertise catered to their particular requirements is one notable benefit of outsourcing regulatory affairs for mid-sized pharmaceutical companies. This enables them to successfully negotiate complicated regulatory landscapes while concentrating on the core operations. They may now more successfully compete in the market while still adhering to legal requirements due to this.
This section will go into detail on the healthcare regulatory affairs outsourcing markets in a few key countries, including the United States, the United Kingdom, Spain, Thailand and Indonesia. This part will focus on the key factors that are driving up demand in these countries for the healthcare regulatory affairs outsourcing.
| Countries | CAGR from 2024 to 2034 |
|---|---|
| The United States | 3.40% |
| The United Kingdom | 3.80% |
| Spain | 4.40% |
| Thailand | 5.30% |
| Indonesia | 4.50% |
The United States healthcare regulatory affairs outsourcing ecosystem is anticipated to gain a CAGR of 3.40% through 2034. Continuous innovation in healthcare technology necessitates faster regulatory processes in order to bring novel products to market as quickly as possible.
Outsourcing regulatory affairs enables businesses to use professional expertise and resources to speed approvals, assuring rapid market access while conforming to regulatory requirements.
The healthcare regulatory affairs outsourcing market in the United Kingdom is expected to expand with a 3.80% CAGR through 2034. Brexit, the United Kingdom's exit from the European Union, still causes regulations in the healthcare industry to be out of compliance with EU standards.
Companies who operate in both the United Kingdom's and the European Union's markets face difficulties as a result of this possible regulatory divergence since they have to deal with several regulatory regimes.
After Brexit, specialized knowledge becomes necessary to comprehend and abide by the changing British rules. Companies may conveniently acquire this knowledge by outsourcing regulatory affairs, which guarantees that they can maintain compliance and adjust to new needs while concentrating on their core business operations.
The healthcare regulatory affairs outsourcing ecosystem in Spain is anticipated to develop with a 4.40% CAGR from 2024 to 2034.Spain's distinct cultural and linguistic characteristics necessitate specialized expertise for most effective regulatory compliance.Regulatory affairs might be outsourced to companies with local knowledge to enable more efficient understanding and communication of regulations.
The healthcare regulatory affairs outsourcing industry in Thailand is anticipated to reach a 5.30% CAGR from 2024 to 2034. The healthcare industry in Thailand is at present aimed at aligned its regulations with that of the international norms and standards.
This step requires immense expertise and knowledge, pushing them towards outsourcing agencies. Regulatory affairs outsourcing provides access to expert knowledge necessary for effectively navigating these dynamic regulatory regimes.
The healthcare regulatory affairs outsourcing ecosystem in Indonesia is likely to evolve with a 4.50% CAGR during the forecast period.
Indonesia has got certain strict regulatory bodies for various medical devices and pharmaceutical drugs. These regulations are stated by bodies like the National Agency of Drug and Food Control (NADFC) functioning under the Indonesian Ministry of Health (MoH).
In order to comply with the changing regulations from these bodies, companies require investments to overcome the hurdles. Market players in Indonesia, thus, take help from various healthcare companies to get large scale investments to meet regulatory compliance.
Market players are actively offering specialized regulatory assistance to biotechnology, pharmaceutical, and medical device companies within the healthcare regulatory affairs outsourcing market.
They provide proficiency in navigating through intricate regulatory structures, guaranteeing adherence to legal statutes and guidelines, and hastening the approvals for the research and studies.
Companies also provide a variety of services, such as pharmacovigilance, submission preparation, regulatory strategy development, and compliance monitoring. They want to reduce the regulatory restrictions consumers face in order to promote healthcare facilities more efficiently and in conformity with quality standards.
This suggests that the market players are simply aimed at easing down the various restrictions that organizations face due to legal restrictions. The key players in this market include:
Key Development by Market Players
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.70% from 2024 to 2034 |
| Market value in 2024 | US$ 2,118.60 million |
| Market value in 2034 | US$ 4,052.30 million |
| Base Year for Estimation | 2023 |
| Historical Data | 2018 to 2023 |
| Forecast Period | 2024 to 2034 |
| Quantitative Units | US$ million for value |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Countries Profiled |
|
| Key Companies Profiled |
|
| Customisation Scope | Available on Request |
The healthcare regulatory affairs outsourcing market is expected to garner a 6.70% CAGR from 2024 to 2034.
By 2024, the global healthcare regulatory affairs outsourcing market is likely to gain US$ 2,118.60 million.
By 2034, the healthcare regulatory affairs outsourcing market valuation is likely to reach a sum of US$ 4,052.30 million.
The healthcare regulatory affairs outsourcing industry in the United States is likely to rise at a 3.40% CAGR during the forecast period.
The regulatory writing and publishing segment is likely to gain traction in the global healthcare regulatory affairs outsourcing market with a 33.60% market share in 2023.
The mid-size pharmaceutical companies are likely to be the dominant end user of healthcare regulatory affairs outsourcing, with a 29.20% market share in 2023.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Services 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Services, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Services, 2024 to 2034 5.3.1. Regulatory Writing and Publishing 5.3.2. Regulatory Submissions 5.3.3. Clinical Trial Applications 5.3.4. Product Registrations 5.3.5. Regulatory Consulting 5.3.6. Legal Representation 5.4. Y-o-Y Growth Trend Analysis By Services, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Services, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034 6.3.1. Pharmaceutical Companies 6.3.2. Biotechnology Companies 6.3.3. Medical Devices Manufacturer 6.3.4. Food and Beverage Companies 6.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Services 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Services 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Services 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Services 9.3.3. By End User 9.4. Key Takeaways 10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. UK 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Services 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Services 10.3.3. By End User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Services 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Services 11.3.3. By End User 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Services 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Services 12.3.3. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Services 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Services 13.3.3. By End User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Services 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Services 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Market Share Analysis, 2023 15.1.1.1. By Services 15.1.1.2. By End User 15.2. Canada 15.2.1. Market Share Analysis, 2023 15.2.1.1. By Services 15.2.1.2. By End User 15.3. Brazil 15.3.1. Market Share Analysis, 2023 15.3.1.1. By Services 15.3.1.2. By End User 15.4. Mexico 15.4.1. Market Share Analysis, 2023 15.4.1.1. By Services 15.4.1.2. By End User 15.5. Germany 15.5.1. Market Share Analysis, 2023 15.5.1.1. By Services 15.5.1.2. By End User 15.6. UK 15.6.1. Market Share Analysis, 2023 15.6.1.1. By Services 15.6.1.2. By End User 15.7. France 15.7.1. Market Share Analysis, 2023 15.7.1.1. By Services 15.7.1.2. By End User 15.8. Spain 15.8.1. Market Share Analysis, 2023 15.8.1.1. By Services 15.8.1.2. By End User 15.9. Italy 15.9.1. Market Share Analysis, 2023 15.9.1.1. By Services 15.9.1.2. By End User 15.10. Poland 15.10.1. Market Share Analysis, 2023 15.10.1.1. By Services 15.10.1.2. By End User 15.11. Russia 15.11.1. Market Share Analysis, 2023 15.11.1.1. By Services 15.11.1.2. By End User 15.12. Czech Republic 15.12.1. Market Share Analysis, 2023 15.12.1.1. By Services 15.12.1.2. By End User 15.13. Romania 15.13.1. Market Share Analysis, 2023 15.13.1.1. By Services 15.13.1.2. By End User 15.14. India 15.14.1. Market Share Analysis, 2023 15.14.1.1. By Services 15.14.1.2. By End User 15.15. Bangladesh 15.15.1. Market Share Analysis, 2023 15.15.1.1. By Services 15.15.1.2. By End User 15.16. Australia 15.16.1. Market Share Analysis, 2023 15.16.1.1. By Services 15.16.1.2. By End User 15.17. New Zealand 15.17.1. Market Share Analysis, 2023 15.17.1.1. By Services 15.17.1.2. By End User 15.18. China 15.18.1. Market Share Analysis, 2023 15.18.1.1. By Services 15.18.1.2. By End User 15.19. Japan 15.19.1. Market Share Analysis, 2023 15.19.1.1. By Services 15.19.1.2. By End User 15.20. South Korea 15.20.1. Market Share Analysis, 2023 15.20.1.1. By Services 15.20.1.2. By End User 15.21. GCC Countries 15.21.1. Market Share Analysis, 2023 15.21.1.1. By Services 15.21.1.2. By End User 15.22. South Africa 15.22.1. Market Share Analysis, 2023 15.22.1.1. By Services 15.22.1.2. By End User 15.23. Israel 15.23.1. Market Share Analysis, 2023 15.23.1.1. By Services 15.23.1.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Services 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Accell Clinical Research, LLC 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Charles River Laboratories 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Syneos Health 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Laboratory Corporation of America Holdings 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. ICON PLc. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. IQVIA 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Medpace, Inc. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. PAREXEL International Corporation 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Thermo Fisher Scientific Inc. (PPD) 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Promedica International 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. WuXi App Tec 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Healthcare Regulatory Affairs Outsourcing Market
